Colorectal Research Unit, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.
World J Surg. 2023 Sep;47(9):2267-2278. doi: 10.1007/s00268-023-07041-1. Epub 2023 May 4.
Hospital length of stay (LOS) has been used as a surgical quality metric. This study seeks to determine the safety and feasibility of right colectomy as a ≤24-h short-stay procedure for colon cancer patients.
This was a retrospective cohort study using the ACS-NSQIP database and its Procedure Targeted Colectomy database (2012-2020). Adult patients with colon cancer who underwent right colectomies were identified. Patients were categorized into LOS ≤1 day (≤24-h short-stay), LOS 2-4 days, LOS 5-6 days, and LOS ≥7 days groups. Primary outcomes were 30-day overall and serious morbidity. Secondary outcomes were 30-day mortality, readmission, and anastomotic leak. The association between LOS and overall and serious morbidity was assessed using multivariable logistic regression.
19,401 adult patients were identified, with 371 patients (1.9%) undergoing short-stay right colectomies. Patients undergoing short-stay surgery were generally younger with fewer comorbidities. Overall morbidity for the short-stay group was 6.5%, compared to 11.3%, 23.4%, and 42.0% for LOS 2-4 days, LOS 5-6 days, and LOS ≥7 days groups, respectively (p < 0.001). There were no differences in anastomotic leak, mortality, and readmission rates in the short-stay group compared to patients with LOS 2-4 days. Patients with LOS 2-4 days had increased odds of overall morbidity (OR 1.71, 95% CI 1.10-2.65, p = 0.016) compared to patients with short-stay but no differences in odds of serious morbidity (OR 1.20, 95% CI 0.61-2.36, p = 0.590).
≤24-h short-stay right colectomy is safe and feasible for a highly-select group of colon cancer patients. Optimizing patients preoperatively and implementing targeted readmission prevention strategies may aid patient selection.
住院时间(LOS)一直被用作外科手术质量指标。本研究旨在确定右结肠切除术作为结肠癌患者≤24 小时短住院程序的安全性和可行性。
这是一项使用 ACS-NSQIP 数据库及其程序靶向结肠切除术数据库(2012-2020 年)的回顾性队列研究。确定接受右结肠切除术的结肠癌成年患者。患者分为 LOS≤1 天(≤24 小时短住院)、LOS2-4 天、LOS5-6 天和 LOS≥7 天组。主要结果是 30 天的总体和严重发病率。次要结果是 30 天死亡率、再入院和吻合口漏。使用多变量逻辑回归评估 LOS 与总体和严重发病率之间的关系。
确定了 19401 名成年患者,其中 371 名患者(1.9%)接受了短住院右结肠切除术。接受短期手术的患者通常更年轻,合并症更少。短期手术组的总发病率为 6.5%,而 LOS2-4 天、LOS5-6 天和 LOS≥7 天组分别为 11.3%、23.4%和 42.0%(p<0.001)。短期手术组与 LOS2-4 天组在吻合口漏、死亡率和再入院率方面无差异。与 LOS2-4 天组相比,LOS2-4 天组的总体发病率(OR1.71,95%CI1.10-2.65,p=0.016)增加,但严重发病率的几率(OR1.20,95%CI0.61-2.36,p=0.590)无差异。
≤24 小时短住院右结肠切除术对于高度选择的结肠癌患者是安全可行的。优化患者术前情况并实施有针对性的再入院预防策略可能有助于患者选择。